About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
B
Hormone Deficiencies After Cancer: Diagnosis, Risks, & Benefits of Treatment
By
Masonic Cancer Center, University of Minnesota
FEATURING
Bradley Miller
By
Masonic Cancer Center, University of Minnesota
FEATURING
Bradley Miller
208 views
May 22, 2023
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
14:57
Penn Medicine
The Radiologist's Approach to Assessing Cancer Risk of Thyroid …
Feat.
J. Langer
27:51
Keck School of Medicine of USC
Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…
Feat.
R. Michael Tuttle
21:12
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Ca…
Feat.
N. Saba
29:25
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
Feat.
Y. Chae
25:55
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "News in Head&Neck Cancers"
Feat.
P. Bossi
14:49
Vivek Subbiah
Year in Review: Precision Medicine
15:11
Insights from 2024 ACP Annual Meeting
ACP 2024 Insights: Cancer of Unknown Primary
Feat.
S. Brondfield
18:07
Nebraska Oncology Society
NOS ASCO® 2023 Review: Nasopharynx Cancer
Feat.
E. Sherman
21:37
Keck School of Medicine of USC
Is It Possible? Thyroglobulin as a Tumor Marker after Lobectomy for …
Feat.
T. Angell
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
42:49
Yale Cancer Center
Parathyroid Disease and Tumors
Feat.
C. Gibson
28:21
Houston Methodist
Palliative Medicine in Cancer Patients
Feat.
E. De Leon
13:27
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Head & Neck Cancer Highlights
Feat.
N. Saba
09:28
Yale Cancer Center
The Future of Lung Cancer Care
Feat.
M. Davies
15:16
Penn Medicine
The Approach to a Patient with a Thyroid Nodule: Updating "The …
Feat.
Z. Baloch
13:47
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…
Feat.
V. Subbiah
51:20
Obafemi Awolowo University
Hypercalcaemia & Hypocalcaemia
Feat.
D. Soyoye
26:27
Keck School of Medicine of USC
Too Much or Not Enough: When to Use Radioactive Iodine for Different…
Feat.
V. J. Bernet
29:54
Jefferson Health
Recent Advances in Treatment of Thyroid Cancer With Precision Medici…
Feat.
M. Brose
13:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL…
Feat.
P. Bossi
